Liraglutide yog ib qho hluavtaws glucagon-zoo li peptide-1 (GLP-1) receptor agonist nrog ntau dua 97% sib npaug zoo ib yam li tib neeg GLP-1. Nws tus lej CAS yog 204656-20-2, nws cov mis molecular yog C172H265N43O51, thiab nws qhov hnyav molecular yog 3751.20. Raws li ib tug high-purity bioactive molecule, nws purity feem ntau mus txog 99.95%, thiab nws zoo nkaus li ib tug dawb los yog off-dawb khoom hmoov. Kev cia khoom yog nruj heev; Cov hmoov yuav tsum tau muab khaws cia rau hauv lub teeb-tiv thaiv, kaw lub thawv ntawm -80℃lossis -20 degree, thiab tom qab tawg, nws yuav tsum tau khaws cia ntawm -80 degree. Cov ntim ntau npaum li cas suav nrog 1mg, 5mg, 10mg, 25mg, 50mg, thiab txawm tias 100mg.
Ua haujlwm tau zoo, liraglutide ua haujlwm ntau yam kev tswj hwm lub cev los ntawm kev khi rau tib lub receptor raws li endogenous metabolic hormone GLP-1. Nws tsis tsuas yog txhawb nqa cov tshuaj insulin tso tawm thiab txo qis glucagon secretion los tswj cov ntshav qab zib, tab sis kuj ua rau lub plab zom mov, txo qis qab los noj mov, thiab txhawb kev rog metabolism.
Nws qhov txiaj ntsig tseem ceeb nyob hauv nws qhov kev hloov pauv cov qauv molecular tshwj xeeb (ntxiv cov roj fatty acid sab saw ntawm lysine txoj haujlwm 26), uas kov yeej qhov tsis zoo degradation ntawm ntuj GLP-1, tso cai rau cov teebmeem ntev nrog tsuas yog ib qho kev txhaj tshuaj subcutaneous txhua hnub. Tsis tas li ntawd, nws qhia tau hais tias kev kho mob zoo heev hauv kev txo cov ntshav qab zib thiab poob phaus, thiab txo cov kev pheej hmoo ntawm cov teeb meem loj hauv plawv hauv cov neeg mob ntshav qab zib hom 2 thiab kab mob plawv.
Txawm li cas los xij, liraglutide kuj tseem muaj qhov tsis zoo thiab kev txwv. Ua ntej, raws li ib tug kws tshuaj, nws muaj nruj contraindications, xws li keeb kwm los yog tsev neeg keeb kwm ntawm medullary thyroid carcinoma, thiab yog contraindicated nyob rau hauv cev xeeb tub thiab pub niam mis. Qhov thib ob, kev tsis zoo ntawm plab hnyuv (xws li xeev siab, raws plab, thiab ntuav) muaj ntau heev, tshwj xeeb tshaj yog thaum pib kho. Tsis tas li ntawd, thaum siv ua ke nrog sulfonylureas, nws ua rau muaj kev pheej hmoo ntawm hypoglycemia.
Nyob rau hauv cov nqe lus ntawm daim ntawv thov, liraglutide feem ntau yog tsom rau cov tshuaj kho mob thiab kev tshawb fawb tshawb fawb. Clinically, nws yog dav siv rau kev tswj glycemic rau cov neeg laus uas muaj ntshav qab zib hom 2 thiab ntev - tswj qhov hnyav hauv cov neeg mob rog lossis rog. Hauv kev tshawb fawb, nws yog siv los ua GLP-1 receptor agonist rau hauv vitro thiab hauv vivo kev tshawb fawb txog kev mob ntshav qab zib hom 2, metabolic syndrome, thiab lwm txoj hauv kev ntawm tes (xws li AMPK / SREBP1 txoj hauv kev).
Ntau tshaj 10 xyoo ntawm Export Experience
Peb tau ua tiav kev pabcuam cov neeg siv khoom hauv ntau dua 10 lub tebchaws, nrog kev xa khoom zoo thiab cov khoom zoo ib yam.
High Purity thiab ruaj khov khoom
Tag nrho cov khoom muaj ib tug purity ntawm ntau dua los yog sib npaug li 99%, yog kuaj sim, thiab muaj cov khoom ruaj khov rau ntev - khoom.
OEM / Me Hom Kev Pabcuam Muaj
Cov kev xaiv hloov tau yooj yim, suav nrog kev sau npe, ntim khoom, thiab kev txhawb nqa tsim, los pab koj lub hom phiaj loj hlob.
Ntiaj teb no Shipping, Discreet Ntim
Ceev ceev, ruaj ntseg, thiab taug qab thoob ntiaj teb shipping -kev txiav txim siab shipping xaiv muaj.
Teb Cov Neeg Siv Khoom
Peb muab kev pabcuam ua ntej- muag thiab tom qab- kev muag khoom. Peb muab cov lus teb sai, taug qab qhov hloov tshiab, thiab kev txhawb nqa kev koom tes ntev ntev.
Cim npe nrov: siab-zoo peptide liraglutide 5mg/vial, Tuam Tshoj siab-zoo peptide liraglutide 5mg/vial manufacturers, lwm tus neeg, Hoobkas
